Table 2.
Multiple linear regression model for predicting serum IL-1B using age, gender, BMI, smoking status, TB, NTM infection, lung abscess, other acute respiratory infections, cancer, COPD, AIP, sarcoidosis, other interstitial diseases, diabetes mellitus, hypertension, cardiac disease, cerebrovascular disease, systemic CS or IS therapy, and pulmonary surgery history as covariates in all the subjects with chronic pulmonary aspergillosis.
| Comorbid conditions | β Coefficient | Standard error | P value | |
|---|---|---|---|---|
| TB | None (reference) | — | — | — |
| Treated | 0.003 | 0.106 | 0.978 | |
| Active/being treated | 0.475 | 0.138 | 0.001 | |
| NTM infection | 0.538 | 0.196 | 0.006 | |
| Lung abscess | 0.975 | 0.304 | 0.001 | |
| Other acute respiratory infection | 0.547 | 0.151 | 0.000 | |
| Cancer | 0.542 | 0.147 | 0.000 | |
| COPD | None (reference) | — | — | — |
| Stable | 0.119 | 0.102 | 0.247 | |
| Acute | 0.612 | 0.164 | 0.000 | |
| AIP | 0.818 | 0.305 | 0.008 | |
| Sarcoidosis | 0.407 | 0.185 | 0.028 | |
| Systemic CS or IS therapy | −0.297 | 0.144 | 0.039 | |
AIP: acute interstitial pneumonia; COPD: chronic obstructive pulmonary disease; CS: corticosteroid; ILD: interstitial lung disease; IS: immunosuppressive; NTM: nontuberculous mycobacterium.